Applied Biologics
Private Company
Funding information not available
Overview
Applied Biologics is a private, commercial-stage biotech company specializing in amniotic membrane-derived allografts for wound care and orthopedic applications. Founded in 2010/2012 and headquartered in San Diego with a state-of-the-art manufacturing facility in Scottsdale, Arizona, the company has vertically integrated operations from tissue recovery to product distribution. Its primary focus is on the XWRAP® product family, which is currently being evaluated in a pivotal multi-center randomized controlled trial for diabetic foot ulcers, with interim data published in 2025. The company positions itself on domestic manufacturing, high-quality standards, and clinical evidence generation.
Technology Platform
Proprietary processing of minimally manipulated human amniotic membrane into dehydrated allografts for use as protective barriers and wound covers. The platform focuses on aseptic recovery and techniques to enhance handling, biodegradability, and prolonged performance.
Opportunities
Risk Factors
Competitive Landscape
Applied Biologics competes in the crowded amniotic membrane allograft and advanced wound care market against companies like Organogenesis (PuraPly®, Affinity), MiMedx (Epifix®, EpiCord), and Smith & Nephew, as well as numerous smaller tissue banks. Differentiation is based on proprietary processing, product formats, clinical evidence, and supply chain control.